Other · developed by Rockwell Medical
Ferric pyrophosphate is an iron-containing compound administered intravenously during hemodialysis to supplement iron in patients with end-stage renal disease.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT04689932 | Phase 4 | End Stage Renal Disease | Completed | RMTI |
| NCT04239391 | Phase 3 | End Stage Renal Disease | Unknown | RMTI |
| NCT01503021 | Phase 3 | End Stage Renal Disease | Completed | RMTI |
| NCT01320202 | Phase 3 | Renal Failure Chronic Requiring Hemodialysis | Completed | RMTI |
| NCT01286012 | Phase 2 | End Stage Renal Disease | Completed | RMTI |
| NCT00548249 | Phase 2 | End-Stage Renal Disease (ESRD) | Completed | RMTI |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Chronic Kidney DiseaseEnd Stage Renal DiseaseEnd-Stage Renal Disease (ESRD)Renal Failure Chronic Requiring Hemodialysis
Updated Oct 3, 2026. Something wrong or missing? Report it on the RMTI page.
See RMTI's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
RMTI catalysts and pipeline →